Authors: Shaharabany, M Abramovitch, R Kushnir, T Tsarfaty, G Ravid-Megido, M Horev, J Ron, R Itzchak, Y Tsarfaty, I

Citation: M. Shaharabany et al., In vivo molecular imaging of Met tyrosine kinase growth factor receptor activity in normal organs and breast tumors, CANCER RES, 61(12), 2001, pp. 4873-4878

Authors: Firon, M Shaharabany, M Altstock, RT Horev, J Abramovici, A Resau, JH Vande Woude, GF Tsarfaty, I

Citation: M. Firon et al., Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells, ONCOGENE, 19(20), 2000, pp. 2386-2397

Authors: Tsarfaty, I Alvord, WG Resau, JH Altstock, RT Lidereau, R Bieche, I Bertrand, F Horev, J Klabansky, RL Keydar, I Vande Woude, GF

Citation: I. Tsarfaty et al., Alteration of Met protooncogene product expression and prognosis in breastcarcinomas, ANAL QUAN C, 21(5), 1999, pp. 397-408